Clinical trial technology company continues to grow rapidly as pharmaceutical companies prioritize improving the experience for patients, caregivers, and sites
BOSTON and DENVER, Aug. 23, 2022 /PRNewswire-PRWeb/ -- ClinOne, the Adaptive Experience platform for clinical trial participants, is among a select number of companies invited to present at the Rocky Mountain Life Sciences Investor & Partnering Conference (website), September 13-14, 2022 in Vail, Colorado.
"We're honored to be invited to participate once again in this important conference to share our remarkable story with investors and industry associates," ClinOne Founder and Chief Solutions Officer Rob Bohacs (LinkedIn) said. "We continue to scale our business at a rapid pace as sponsors, CROs, and research institutions recognize that our adaptive experiences platform makes it easier than ever before for patients and caregivers to enroll, stay engaged, and maintain higher compliance in global clinical trials."
The Rocky Mountain Life Sciences Investor & Partnering Conference brings together high-profile investors and representatives from life sciences companies in the Rocky Mountain region to learn about new breakthroughs from emerging life sciences companies like ClinOne. The Conference is organized by the Colorado BioScience Association.
About ClinOne
ClinOne provides adaptive experiences for participants in clinical trials. By offering choice to patients, caregivers, and site staff, our technology makes it easier to stay active, compliant, and comfortable in a trial – thereby expanding enrollment access, reducing drop-out rate, and shortening conduct timelines. Our true single platform features solutions for local HCP trial awareness, remote and on-site eConsent, Uber Health, medication adherence, and a DCT portal. ClinOne stands alone with the industry's fastest implementation (average 2-4 weeks), cost-efficient scale, and seamless API integrations for complex therapeutic areas such as Oncology, CNS, and Rare Disease in over 60 languages. To learn why more than 55 sponsors and CROs trust ClinOne in 100+ currently active studies to connect, inform, and empower participants to take control of their clinical trial experience, begin a conversation with our experts at http://www.clinone.com.
Media Contact
Brenda Nashawaty, ClinOne, 6176883253, [email protected]
SOURCE ClinOne
Share this article